Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Costantine Albany | Researchclopedia

Back to researchers

Costantine Albany

Horizon Oncology Center ORCID

175

Works

3,459

Citations

30

h-index

66

i10-index

Research Topics

Testicular diseases and treatments Sarcoma Diagnosis and Treatment Prostate Cancer Treatment and Research

Affiliations

Université Paris-Sud2017–2017

Indiana University Health2011–2022

St. Luke's-Roosevelt Hospital Center2009–2011

Memorial Sloan Kettering Cancer Center2010–2010

University of Indianapolis2018–2018

Top Works

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

Silke Gillessen,Nicolas Sauvé,et al.

2021221 citations

Neuroblastoma Research and Treatments

Bladder and Urothelial Cancer Treatments

Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012

Maha Hussain,Stephanie Daignault‐Newton,et al.

2017208 citations

Long-term toxicity of cisplatin in germ-cell tumor survivors

Michal Chovanec,Mohammad Abu Zaid,et al.

2017199 citations

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206

Nabil Adra,Lawrence H. Einhorn,et al.

2017191 citations

High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience

Nabil Adra,Rafat Abonour,et al.

2017173 citations

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium

J. Beyer,Laurence Collette,et al.

2021161 citations

Extragonadal germ cell tumors

Costantine Albany,Lawrence H. Einhorn

2013133 citations

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study

Costantine Albany,Mary J. Brames,et al.

2012115 citations

Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes

Matthew D. Galsky,Huan Wang,et al.

2017113 citations